Stock 002826 TIBET AIM PHARM. INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tibet AIM Pharm. Inc.

Equities

002826

CNE100002C39

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
8.93 CNY +1.13% Intraday chart for Tibet AIM Pharm. Inc. -3.67% -24.77%
Apr. 25 Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023. CI

Business Summary

TIBET AIM PHARM INC is a China-based company principally engaged in the research, design, manufacture and distribution of chemical drugs and Chinese patent medicine. The Company’s products include self-manufacturing medicine and third-party medicine. Self-manufacturing medicine includes miglitol tablets, hongjinxiaojie tablet, aceclofenac enteric-coated tablets, montmorillonite powder, as well as domperidone tablets, among others. Its third-party medicine includes gualoupi injection, nalmefene hydrochloride injection, oral liquid for children, cefotaxime sodium for injection, as well as carbetocin injection. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 439

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Drugs and Chinese Medicine
100.0 %
- - 667 100.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
857 100.0 % 667 100.0 % -22.14%

Managers

Managers TitleAgeSince
Ke Xu CEO
 Chief Executive Officer 46 09-12-31
Min Zhou DFI
 Director of Finance/CFO 37 23-01-31
Ling Li CHM
 Chairman 55 20-09-30
Yu Zhang BRD
 Director/Board Member 44 04-12-31
Zhan Zhou BRD
 Director/Board Member 55 14-12-11
Qian Jin Li IRC
 Investor Relations Contact 47 04-05-31

Members of the board

Members of the board TitleAgeSince
Ming Hu BRD
 Director/Board Member 53 21-09-12
Zhan Zhou BRD
 Director/Board Member 55 14-12-11
Qian Jin Li IRC
 Investor Relations Contact 47 04-05-31
Ke Xu CEO
 Chief Executive Officer 46 09-12-31
Xing Gang Xiao BRD
 Director/Board Member 50 21-09-12
Yu Zhang BRD
 Director/Board Member 44 04-12-31
Li Ting Zhao BRD
 Director/Board Member 42 23-03-30
Ling Li CHM
 Chairman 55 20-09-30
Lan Feng BRD
 Director/Board Member 45 21-09-12
Min Zhou DFI
 Director of Finance/CFO 37 23-01-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 190,677,750 118,518,598 ( 62.16 %) 4,000,000 ( 2.098 %) 62.16 %

Shareholders

NameEquities%Valuation
Wanjia Asset Management Co., Ltd.
0.8472 %
1,115,600 0.8472 % 1 M ¥
Goldstate Capital Fund Management Co., Ltd.
0.4310 %
567,600 0.4310 % 698 381 ¥
Western Leadbank Fund Management Co., Ltd
0.3662 %
482,200 0.3662 % 593 304 ¥
Gfund Management Co., Ltd.
0.3117 %
410,400 0.3117 % 504 960 ¥
Broad Fund Management Co. Ltd.
0.1986 %
261,500 0.1986 % 321 752 ¥
Lion Fund Management Co., Ltd.
0.1604 %
211,200 0.1604 % 259 863 ¥
CCB Principal Asset Management Co., Ltd.
0.0228 %
30,000 0.0228 % 36 912 ¥
Nuode Asset Management Co., Ltd.
0.0125 %
16,500 0.0125 % 20 302 ¥
Fortune & Royal Asset Management Co., Ltd.
0.008657 %
11,400 0.008657 % 14 027 ¥
Bosera Asset Management Co., Ltd.
0.005695 %
7,500 0.005695 % 9 228 ¥

Company contact information

Tibet Aim Pharm., Inc.

37/F, Building B Liangjiang International

610000, Chengdu

+

http://www.emyy.cn
address Tibet AIM Pharm. Inc.(002826)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
TIBET AIM PHARM. INC. Stock Tibet AIM Pharm. Inc.
-24.77% 227M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.22% 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.57% 592B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.85% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.48% 319B
ABBVIE INC. Stock AbbVie Inc.
-0.12% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.55% 238B
NOVARTIS AG Stock Novartis AG
+6.65% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-6.09% 203B
PFIZER, INC. Stock Pfizer, Inc.
-3.37% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002826 Stock
  4. Company Tibet AIM Pharm. Inc.